Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
16-30 of 2101 results
Synthetic Biologics wins research contract from US CDC
Synthetic Biologics has secured a contract from the Centers for Disease Control and Prevention (CDC) for microbiome assessment and intervention to address antibiotic resistance.
Contract Research & Services > Contract Research > News
Daiichi Sankyo enters into immuno-oncology research collaboration with AgonOx
Daiichi Sankyo has entered into a strategic collaboration with AgonOx, a privately held biotechnology firm developing a pipeline of novel immunotherapy drugs targeting key regulators of the immune response to cancer, to develop an undisclosed immuno-oncology target.
Contract Research & Services > Contract Research > News
Catabasis, Sarepta partner to explore combination drug for Duchenne muscular dystrophy
Catabasis Pharmaceuticals and Sarepta Therapeutics have announced a joint research collaboration to explore a combination drug treatment approach for Duchenne muscular dystrophy (DMD).
Contract Research & Services > Contract Research > News
Oncodesign to buy GSK's French research center
Oncodesign has agreed to acquire the François Hyafil Research Centre located in Villebon-sur-Yvette (Essonne) from GSK, part of the Paris Saclay innovation cluster, including transfer of the team of highly qualified drug discovery staff located at the site (anticipated to be 57 employees).
Contract Research & Services > Contract Research > News
Bristol-Myers to test Opdivo with Nektar Therapeutics drug in five tumor types
By PBR Staff Writer
Bristol-Myers Squibb (BMS) is evaluating the use of its cancer immunotherapy, Opdivo, in combination with an experimental drug from Nektar Therapeutics to treat several cancers.
Contract Research & Services > Contract Research > News
Evotec forms research collaboration with Inserm Transfert in oncology
Evotec has entered into a research collaboration with Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research (Inserm).
Contract Research & Services > Contract Research > News
Takeda, Affilogic partner to develop CNS therapies
Takeda Pharmaceutical Company and Affilogic have entered into a research collaboration to explore using Affilogic’s Nanofitins platform in therapies targeting the central nervous system (CNS).
Contract Research & Services > Contract Research > News
Bayer, Evotec join hands to develop new treatments for kidney diseases
By PBR Staff Writer
Bayer and German firm Evotec have partnered to develop to new treatments for kidney diseases.
Contract Research & Services > Contract Research > News
Redx Pharma confirms potential role for Porcupine inhibitor in cancer immunotherapy
Redx Pharma has confirmed that its lead cancer treatment, the Porcupine inhibitor (RXC004), has a potential role in cancer immunotherapy.
Contract Research & Services > Contract Research > News
Sanofi, Verily Life Sciences create new JV to develop diabetes management platform
By PBR Staff Writer
French pharmaceutical firm Sanofi and Alphabet subsidiary Verily Life Sciences have launched a new joint venture (JV) called Onduo, to develop comprehensive diabetes management platform.
Contract Research & Services > Contract Research > News
Biothera collaborates with Merck for combination cancer immunotherapy trials in multiple indications
Biothera Pharmaceuticals announced a collaboration with Merck to expand the companies’ ongoing clinical program evaluating KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 inhibitor, in combination with Biothera’s Imprime PGG, a Pathogen Associated Molecular Patterning molecule, or PAMP.
Contract Research & Services > Contract Research > News
Xycrobe signs research deal with Johnson & Johnson Consumer
Xycrobe Therapeutics has entered into a research agreement with Johnson & Johnson Consumer.
Contract Research & Services > Contract Research > News
Abeona, EBRP and EB MRF to collaborate on epidermolysis bullosa treatments
Abeona Therapeutics, EB Research Partnership (EBRP) and EB Research Medical Foundation (EBMRF) announced a collaboration focusing on gene therapy treatments for epidermolysis bullosa (EB), a group of devastating rare genetic skin disorders impacting children; characterized by skin blisters and erosions all over the body.
Contract Research & Services > Contract Research > News
Proteostasis completes preclinical milestone in collaboration with Astellas Pharma
Proteostasis Therapeutics has completed a key preclinical milestone in its collaboration with Astellas Pharma.
Contract Research & Services > Contract Research > News
Codexis completes obligations under research and development deal with biopharmaceutical firm
Codexis has completed its obligations under a collaborative research and development agreement with a leading global biopharmaceutical company.
Contract Research & Services > Contract Research > News
16-30 of 2101 results